Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Diabetes, Parkinson's disease
Some Diabetes Drugs May Protect Against Dementia and Parkinson's
Scientists found a 22 percent lower risk of any dementia and Parkinson's among a group taking SGLT2 inhibitors for type 2 diabetes.
Diabetes Drug Linked to 20% Lower Risk of Dementia, Parkinson's
A class of drugs used to treat diabetes has been linked to a 20% lower risk of dementia and Parkinson's disease. | Neuroscience
Study: Diabetes Drug May Cut Risk of Alzheimer’s and Parkinson’s by 20%
SGLT2 inhibitors, a class of diabetes drugs, may reduce the risk of Alzheimer’s, vascular dementia, and Parkinson’s disease, according to a large study. Results showed a 20% to 30% lower risk for these conditions,
Some diabetes meds might lower risk of dementia, Parkinson's
A specific class of diabetes drug appears to lower people's risk for dementia and Parkinson's disease, a new study shows.
These Diabetes Drugs Could Help Lower Your Risk of Dementia, Parkinson’s
According to a new study, certain diabetes medications may significantly reduce this risk. These drugs, called gliflozins or SGLT2 inhibitors, stop the kidneys from reabsorbing too much blood glucose to improve blood sugar levels.
Type 2 diabetes drugs could lower dementia, Parkinson's disease risk
Researchers have found that people who take a type of type 2 diabetes drugs SGLT2 inhibitors have a significantly lower risk of dementia, overall, and of Alzheimer's disease and Parkinson's, in particular.
Diabetes drugs may protect against dementia
New research shows diabetes drugs may significantly reduce the risk of dementia, Alzheimer's, and Parkinson’s disease.
Research shows diabetes drug could reduce dementia risk. Here’s how the two diseases may be linked
Some diabetes medications linked to lower dementia, Parkinson's disease risk
Gliflozins, another name for sodium-glucose cotransporter-2 (SGLT2) inhibitors, were the subject of the investigation. By encouraging the kidneys to eliminate sugar from the body through urine, they reduce blood sugar.
22h
New study to investigate non-invasive treatment for dementia and Parkinson’s
A first-of-its-kind study will use ultrasound and light therapies to investigate targeted treatment of Alzheimer’s disease, ...
27m
on MSN
New study hopes to unlock cure for Parkinson’s disease
A groundbreaking study will investigate
Parkinson’s
disease
in unprecedented detail ... Researchers hope the findings ...
Medscape
13d
Frequency, Timing of Dementia in Parkinson's: New Data
A recent study revealed that dementia in Parkinson's disease may occur less frequently or develop over a longer period than ...
22h
Dementia and Parkinson's 'cure' to be investigated in new first-of-its-kind research
A new study by scientists at Nottingham Trent University will use non-invasive techniques to investigate the targeted ...
Prevention
21h
Why It’s So Important to Detect Alzheimer’s Disease Early
At first, Jonel suspected she was experiencing symptoms of
Parkinson’s
disease
as she had seen her father’s experience ..
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback